VEGFA and hemorrhage: The reason for failure in two eyes (40%) was due to additional treatment other than anti-VEGF and in three eyes (60%), there was decreased BCVA ≥ 0.2; one eye exhibited fibrovascular PED, one exhibited hemorrhage, and one exhibited serous PED in the group with an initial BCVA < 0.3.